Zanubrutinib in AL Amyloidosis Associated With Waldenström Macroglobulinemia and Other B‐Cell Non‐Hodgkin Lymphoma
Wouter Verhaar, Flores Weverling, Jahanzaib Khwaja, Despina Trajanova et autres
0 citationsAmerican Journal of Hematology
Peter E. Westerweel
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
181Publications signalées
4689Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer
Publications récentes
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia
Niels Westra, Elena Ropero Cerro, Edwin Schilder, Marjolijn N Lub-de Hooge et autres
1 citationBlood Neoplasia
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint
Fausto Castagnetti, Massimo Breccia, Elisabetta Abruzzese, Renato Bassan et autres
2 citationsLeukemia
International, prospective study comparing nilotinib versus imatinib with early switch to nilotinib to obtain sustained treatment-free remission (TFR) in patients with chronic myeloid leukemia: The tfr rate at the end of follow-up
Massimo Breccia, Fausto Castagnetti, Elisabetta Abruzzese, Renato Bassan et autres
0 citationsBlood
Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study
Dina Nienke Lokhorst, Yolba Smit, Bart J. F. van den Bemt, Rosella Hermens et autres
0 citationsHaematologica
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial
Fabio Efficace, Laura Cannella, Isabella Capodanno, Rosaria Sancetta et autres
1 citationFrontiers in Oncology
The ‘Stop TPO‐RA in ITP Patients’ study: Clinical and immune modulatory effects of romiplostim tapering
Vivianne S. Nelson, Sufia N. Amini, Tanja Netelenbos, Marina Kartachova et autres
6 citationsBritish Journal of Haematology
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Isabelle Mahé, Marc Carrier, D. Mayeur, Jean Chidiac et autres
152 citationsNew England Journal of Medicine
Associations of various medical nutrition therapy strategies with body composition, and physical and clinical outcomes in acute myeloid leukemia patients undergoing intensive remission-induction treatment: A multicenter prospective correlational study
Rianne van Lieshout, Lidwine W. Tick, Erik A.M. Beckers, Willemijn Biesbroek et autres
4 citationsClinical Nutrition ESPEN
Treatment‐Free Remission Outcomes in a BCR :: ABL1 Digital PCR Selected Clinical Cohort of CML Patients
Camille Kockerols, Peter J.M. Valk, Pauline Hogenbirk, Inge G.P. Geelen et autres
3 citationsEuropean Journal Of Haematology
Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases
Arjen Yousefi, Mark‐David Levin, Jan J. Cornelissen, Peter E. Westerweel
3 citationsAnnals of Hematology
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
Paul J. Hengeveld, Joyce Schilperoord‐Vermeulen, P. Martijn Kolijn, Julie Dubois et autres
1 citationBlood Cancer Journal
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.